• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

10x Genomics, Inc. - Common Stock (NQ:TXG)

34.60 +2.73 (+8.57%)
Official Closing Price Updated: 4:15 PM EDT, Jun 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,651,984
Open 32.74
Bid (Size) 34.00 (100)
Ask (Size) 34.86 (100)
Prev. Close 31.87
Today's Range 32.65 - 35.15
52wk Range 10.47 - 36.59
Shares Outstanding 109,588,527
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Is 10x Genomics (TXG) Stock Soaring Today
Today 11:35 EDT
What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 6.8% in the morning session after Barclays boosted its price target to $40 per shar... 
Via StockStory
News headline image
10x Genomics (TXG): Buy, Sell, or Hold Post Q1 Earnings?
June 19, 2026
The past six months have been a windfall for 10x Genomics’s shareholders. The company’s stock price has jumped 116%, setting a new 52-week high of $34.69 per... 
Via StockStory
Topics Supply Chain

Performance

YTD
+108.2%
+108.2%
1 Month
+40.5%
+40.5%
3 Month
+74.7%
+74.7%
6 Month
+109.7%
+109.7%
1 Year
+220.7%
+220.7%

More News

Read More
News headline image
3 Small-Cap Stocks with Questionable Fundamentals
June 11, 2026
Via StockStory
News headline image
10x Genomics CEO Sells Nearly 30,000 Shares. Here's What That Means for Investors. ↗
June 01, 2026
Via The Motley Fool
Topics Regulatory Compliance
10x Genomics (NASDAQ:TXG) Beats Q1 Estimates But Falls as Revenue Shrinks Year-Over-Year ↗
May 07, 2026
Via Chartmill
News headline image
The 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call
May 14, 2026
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
United Natural Foods Stock Is Up 85%. One Investor Just Sold Out Completely ↗
May 12, 2026
Via The Motley Fool
Topics Economy Supply Chain
News headline image
What to Know About This Fund’s Sale of a Pharma Stock Up 56% in a Year ↗
May 12, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116% ↗
May 12, 2026
Via The Motley Fool
News headline image
1 Cash-Producing Stock on Our Watchlist and 2 We Question
May 11, 2026
Via StockStory
News headline image
10x Genomics Q1 Earnings Call Highlights ↗
May 09, 2026
Via MarketBeat
Topics Earnings
News headline image
Why 10x Genomics (TXG) Stock Is Down Today
May 08, 2026
Via StockStory
News headline image
TXG Q1 Deep Dive: Atara Launch, Spatial Platform Transition, and AI-Driven Demand
May 08, 2026
Via StockStory
News headline image
10x Genomics (TXG) Q1 2026 Earnings Transcript ↗
May 07, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
10x Genomics’s (NASDAQ:TXG) Q1 CY2026: Beats On Revenue But Stock Drops
May 07, 2026
Via StockStory
News headline image
10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect
May 05, 2026
Via StockStory
News headline image
1 Unprofitable Stock to Target This Week and 2 That Underwhelm
April 28, 2026
Via StockStory
News headline image
1 Cash-Heavy Stock to Target This Week and 2 We Ignore
April 24, 2026
Via StockStory
News headline image
Why 10x Genomics (TXG) Shares Are Trading Lower Today
April 23, 2026
Via StockStory
Topics Artificial Intelligence Government Stocks
News headline image
3 Overrated Stocks We Keep Off Our Radar
April 17, 2026
Via StockStory
Topics Economy
News headline image
3 Small-Cap Stocks We Steer Clear Of
April 09, 2026
Via StockStory
News headline image
Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know
March 27, 2026
Via StockStory
Topics Economy Government Stocks
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
March 25, 2026
Via The Motley Fool
News headline image
These Are the Only 3 Stocks That Cathie Wood Bought Last Week ↗
March 23, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
3 Reasons to Sell TXG and 1 Stock to Buy Instead
March 20, 2026
Via StockStory
Topics Stocks Supply Chain

Frequently Asked Questions

Is 10x Genomics, Inc. - Common Stock publicly traded?
Yes, 10x Genomics, Inc. - Common Stock is publicly traded.
What exchange does 10x Genomics, Inc. - Common Stock trade on?
10x Genomics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for 10x Genomics, Inc. - Common Stock?
The ticker symbol for 10x Genomics, Inc. - Common Stock is TXG on the Nasdaq Stock Market
What is the current price of 10x Genomics, Inc. - Common Stock?
The current price of 10x Genomics, Inc. - Common Stock is 34.60
When was 10x Genomics, Inc. - Common Stock last traded?
The last trade of 10x Genomics, Inc. - Common Stock was at 06/24/26 04:15 PM ET
What is the market capitalization of 10x Genomics, Inc. - Common Stock?
The market capitalization of 10x Genomics, Inc. - Common Stock is 3.79B
How many shares of 10x Genomics, Inc. - Common Stock are outstanding?
10x Genomics, Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap